Publications by authors named "Matt Westfall"

Claim this Profile
S
Safety and pharmacokinetics of SOR102, an oral bispecific inhibitor of TNF and interleukin-23 in healthy participants and patients with ulcerative colitis: a first-in-human, double-blind, randomised, placebo-controlled, phase 1 trial.
Vipul Jairath, Silvio Danese, Geert R D'Haens, Brian G Feagan, Laurent Peyrin-Biroulet, Matt Westfall

Lancet Gastroenterol Hepatol· January 2026

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Proteomic characterisations of ulcerative colitis endoscopic biopsies associate with clinically relevant histological measurements of disease severity.
Aaron M Gruver, Matt D Westfall, Bradley L Ackermann, Salisha Hill, Ryan D Morrison

J Clin Pathol· September 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cell signaling-based classifier predicts response to induction therapy in elderly patients with acute myeloid leukemia.
Alessandra Cesano, Cheryl L Willman, Kenneth J Kopecky, Urte Gayko, Santosh Putta, Matt Westfall

PLoS One· January 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Development and validation of a single-cell network profiling assay-based classifier to predict response to induction therapy in paediatric patients with de novo acute myeloid leukaemia: a report from the Children's Oncology Group.
Norman J Lacayo, Todd A Alonzo, Urte Gayko, David B Rosen, Matt Westfall

Br J Haematol· July 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Single cell network profiling assay in bladder cancer.
Todd M Covey, Manish A Vira, Matt Westfall, Michael Gulrajani, Michelle Cholankeril

Cytometry A· April 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis